Revvity (RVTY) Other Non-Current Liabilities (2010 - 2026)
Revvity's (RVTY) quarterly Other Non-Current Liabilities came in at $800.9 million in Q2 2026, up 3957.04% YoY from $19.7 million in Q2 2025, and down 0.82% on a QoQ basis from $807.5 million in Q4 2025.
Revvity (RVTY) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Revvity (RVTY) has 17 years of Other Non-Current Liabilities data on file, last reported at $800.9 million in Q2 2026.
- Quarterly Other Non-Current Liabilities rose 3957.04% year-over-year to $800.9 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $800.9 million (up 3957.04% YoY) and the FY2025 annual result came in at $807.5 million, up 3611.95% from the prior year.
- Other Non-Current Liabilities fell to $800.9 million in Q2 2026, from $807.5 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $1.2 billion in Q4 2022 to a low of $19.7 million in Q1 2025.
- A 5-year average of $326.8 million and a median of $47.6 million in 2022 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Other Non-Current Liabilities sank 45.62% — and 2026, when it jumped 3957.04%.
- Tracing RVTY's Other Non-Current Liabilities over 5 years: stood at $1.2 billion in 2022, then plunged by 96.75% to $40.0 million in 2023, then slumped by 45.62% to $21.8 million in 2024, then surged by 3611.95% to $807.5 million in 2025, then retreated by 0.82% to $800.9 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $800.9 million (Q2 2026), $807.5 million (Q4 2025), and $755.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Revvity | 12.76 Bn | 11.90 Bn | 387.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | 800.86 Mn |
| Dec 28, 2025 | 807.46 Mn |
| Sep 28, 2025 | 755.16 Mn |
| Jun 29, 2025 | 21.09 Mn |
| Mar 30, 2025 | 19.74 Mn |
| Dec 29, 2024 | 21.75 Mn |
| Sep 29, 2024 | 846.00 Mn |
| Jun 30, 2024 | 30.54 Mn |
| Mar 31, 2024 | 30.52 Mn |
| Dec 31, 2023 | 40.01 Mn |
| Oct 1, 2023 | 993.05 Mn |
| Jul 2, 2023 | 37.56 Mn |
| Apr 2, 2023 | 43.83 Mn |
| Jan 1, 2023 | 46.62 Mn |
| Oct 2, 2022 | 1.23 Bn |
| Jul 3, 2022 | 48.59 Mn |
| Apr 3, 2022 | 49.83 Mn |
| Jan 2, 2022 | 58.00 Mn |
| Oct 3, 2021 | 1.51 Bn |
| Jul 4, 2021 | 3.33 Mn |